Chris Jakubik
Head of Investor Relations, Kimberly-Clark
Replay available
Kimberly-Clark Corporation (NASDAQ: KMB) Q1 2026 earnings conference call, held 2026-04-28. Replay captured from the company's public earnings webcast.

Head of Investor Relations, Kimberly-Clark
President and Chief Executive Officer, Kimberly-Clark
Analyst, Morgan Stanley
Analyst, UBS
Analyst, Evercore ISI
Analyst, Barclays
Analyst, Wells Fargo Securities
Analyst, Bank of America
Analyst, TD Cowen
Analyst, Rothschild & Co. Redburn
Good morning, everyone. This is Chris Jakubik, Head of Investor Relations at Kimberly-Clark, and thank you for joining us. I'd like to remind everyone that during our comments today, we will make some forward-looking statements that are based on how we see things today. Actual results may differ due to risks and uncertainties, and these are discussed in our earnings release and our filings with the SEC. We will also discuss some non-GAAP financial measures during these remarks. These non-GAAP financial measures should not be considered a replacement for, and should be read together with GAAP results. And you can find the GAAP to non-GAAP reconciliations within our earnings release and the supplemental materials posted at investor.kimberly-clark.com. With that, I will turn it over to Mike for a few opening comments. Okay, thank you, Chris, and thanks to everyone for joining us this morning. Our first quarter results underscore the strong progress we're making toward creating a company unlike any other in our industry today. Our power and care growth engine is enabling Kimberly Clark to continue building industry-leading base business momentum. We are delivering differentiated science-backed innovation at all rungs of the good, better, best ladder. In the first quarter, innovation helped fuel our delivery of solid organic sales growth with volume plus mix growth increasing to 3%. This builds on two consecutive years of broad-based volume plus mix growth. We're building market share across our key focus areas of baby care, women's health, and active aging, and with a second quarter launch slate that's one of our most active ever across the categories and markets where we compete. Our supply chain team continues advancing our commitment to deliver the best product at the...